NASDAQ:COSM Cosmos Health (COSM) Stock Price, News & Analysis $0.35 -0.04 (-10.59%) Closing price 04:00 PM EasternExtended Trading$0.36 +0.01 (+2.45%) As of 04:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Cosmos Health Stock (NASDAQ:COSM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cosmos Health alerts:Sign Up Key Stats Today's Range$0.34▼$0.3850-Day Range$0.39▼$0.7952-Week Range$0.34▼$1.58Volume256,008 shsAverage Volume804,132 shsMarket Capitalization$8.15 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewCosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.Read More… Remove Ads Cosmos Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks28th Percentile Overall ScoreCOSM MarketRank™: Cosmos Health scored higher than 28% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cosmos Health. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cosmos Health are expected to grow in the coming year, from ($0.78) to $0.01 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cosmos Health is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cosmos Health is -0.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCosmos Health has a P/B Ratio of 0.16. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.95% of the float of Cosmos Health has been sold short.Short Interest Ratio / Days to CoverCosmos Health has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cosmos Health has recently decreased by 19.54%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCosmos Health does not currently pay a dividend.Dividend GrowthCosmos Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.95% of the float of Cosmos Health has been sold short.Short Interest Ratio / Days to CoverCosmos Health has a short interest ratio ("days to cover") of 1.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cosmos Health has recently decreased by 19.54%, indicating that investor sentiment is improving significantly. News and Social Media0.6 / 5News SentimentN/A MarketBeat Follows5 people have added Cosmos Health to their MarketBeat watchlist in the last 30 days. This is an increase of 150% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Cosmos Health insiders have bought more of their company's stock than they have sold. Specifically, they have bought $502,164.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders15.61% of the stock of Cosmos Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 12.61% of the stock of Cosmos Health is held by institutions.Read more about Cosmos Health's insider trading history. Receive COSM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cosmos Health and its competitors with MarketBeat's FREE daily newsletter. Email Address COSM Stock News HeadlinesCosmos Health Inc. (NASDAQ:COSM) CEO Buys $64,960.28 in StockMarch 5, 2025 | insidertrades.comNatracare's Certified COSMOS Organic Cleansing Makeup Removal Wipes Now Available at Natural Grocers® Stores NationwideMarch 26, 2025 | finance.yahoo.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 4, 2025 | Porter & Company (Ad)Health Challenges Faced by Astronauts After Space MissionsMarch 20, 2025 | msn.comCosmos Health Inc.: Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth AcceleratesFebruary 26, 2025 | finanznachrichten.deHow does space travel affect astronaut health?February 21, 2025 | reuters.comCosmos Health Inc.: Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1February 19, 2025 | finanznachrichten.deCosmos Health will not proceed with offering under Form S-1February 19, 2025 | markets.businessinsider.comSee More Headlines COSM Stock Analysis - Frequently Asked Questions How have COSM shares performed this year? Cosmos Health's stock was trading at $0.6690 on January 1st, 2025. Since then, COSM shares have decreased by 47.6% and is now trading at $0.3504. View the best growth stocks for 2025 here. When did Cosmos Health's stock split? Shares of Cosmos Health reverse split before market open on Thursday, December 15th 2022. The 1-25 reverse split was announced on Thursday, December 15th 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of Cosmos Health? Shares of COSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Cosmos Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cosmos Health investors own include Meta Platforms (META), NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET) and Builders FirstSource (BLDR). Company Calendar Today4/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Drugs, proprietaries, & sundries Sub-IndustryWholesale Current SymbolNASDAQ:COSM CIK1474167 Webwww.cosmosholdingsinc.com Phone(312) 536-3102FaxN/AEmployees100Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,540,000.00 Net Margins-36.39% Pretax Margin-36.39% Return on Equity-9.39% Return on Assets-5.10% Debt Debt-to-Equity Ratio0.08 Current Ratio1.44 Quick Ratio1.24 Sales & Book Value Annual Sales$56.04 million Price / Sales0.15 Cash FlowN/A Price / Cash FlowN/A Book Value$2.13 per share Price / Book0.17Miscellaneous Outstanding Shares23,260,000Free Float19,629,000Market Cap$8.26 million OptionableOptionable Beta5.49 7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (NASDAQ:COSM) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredEU’s Action Takes Aim At US RetireesTrump's Return Sparks Massive Gold Rush—Is Your 401(k) Ready for the Fallout? With President Trump back and...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cosmos Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cosmos Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.